Principles of toxicology, second edition

Principles of Toxicology, Second Edition

Volumn , Issue , 2006, Pages 1-352

  Stine, Karen E ^a   Brown, Thomas M ^b  

^a ASHLAND UNIVERSITY   (United States)

^b Genectar Com LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85056552540     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Book

References (310)

1. Beck, B.D., Slayton, T.M., Calabrese, E.J., Baldwin, L., and Rudel, R., The use of toxicology in the regulatory process, in Principles and Methods of Toxicology, Hayes, A.W., Ed., Taylor & Francis, Philadelphia, 2001, chap. 2.
2. Bolon, B., Genetically engineered animals in drug discovery and development: a maturing resource for toxicologic research, Basic Clin. Pharmacol. Toxicol., 95, 154, 2004.
3. Bruce, R.D., An up-and-down procedure for acute toxicity testing, Fundam. Appl. Toxicol., 5, 151, 1985.
4. Faustman, E.M. and Omenn, G.S., Risk assessment, in Casarett and Doull’s Toxicology, Klaassen, C.D., Ed., McGraw-Hill, New York, 2001, chap. 4.
5. Gad, S.C., Statistics for toxicologists, in Principles and Methods of Toxicology, Hayes, A.W., Ed., Taylor & Francis, Philadelphia, 2001, chap. 7.
6. Joly, J.M. and Brown, T.M., Metabolism of aspirin and procaine in mice pretreated with O-4-nitrophenyl methyl(phenyl)phosphinate or O-4-nitrophenyl diphenylphosphinate, Toxicol. Appl. Pharmacol., 84, 523, 1986.
7. MacDonald, J., French, J.E., Gerson, R.J., Goodman, J., Inoue, T., Jacobs, A., Kasper, P., Keller, D., Lavin, A., Long, G., McCullough, B., Sistare, F.D., Storer, R., and van der Laan, J.W., The utility of genetically modified mouse assays for identifying human carcinogens: a basic understanding and path forward, The Alternatives to Carcinogenicity Testing Committee ILSI HESI, Toxicol. Sci., 77, 188, 2004.
8. Morton, M.G., Risk analysis and management, Scientific American, July 1993, p. 32.
9. Robertson, C., Idris, N.R.N., and Boyle, P., Beyond classical meta-analysis: can inadequately reported studies be included?, Drug Discovery Today, 9, 924, 2004.
10. Scala, R.A., Risk assessment, in Casarett and Doull’s Toxicology, Amdur, M.O., Doull, J., and Klaassen, C.D., Eds., Pergamon Press, New York, 1991, chap. 31.
11. Sim, M., Case studies in the use of toxicological measures in epidemiological studies, Toxicology, 181/182, 405, 2002.
12. Smith, G.D., Reflections on the limitations to epidemiology, J. Clin. Epidemiol., 54, 325, 2001.
13. Fink, D.W. and Porras, A.G., Pharmacokinetics of ivermectin in animals and humans, in Ivermectin and Abamectin, Campbell, W.C., Ed., Springer-Verlag, Berlin, 1989.
14. Gilman, A.G., Rall, T.W., Nies, A.S., and Taylor, P., The Pharmacological Basis of Therapeutics, 8th ed., Pergamon Press, New York, 1990.
15. Joly, J.M. and Brown, T.M., Metabolism of aspirin and procaine in mice pretreated with O-4-nitrophenyl methyl(phenyl)phosphinate or O-4-nitrophenyl diphenylphosphinate, Toxicol. Appl. Pharmacol., 84, 523, 1989.
16. Klaassen, C.D. and Rozman, K., Absorption, distribution, and excretion of toxicants, in Casarett and Doull’s Toxicology, Amdur, M.O., Doull, J., and Klaassen, C.D., Eds., Pergamon Press, New York, 1991, chap. 3.
17. Mekapati, S.B., Kurup, A., Verma, R.P., and Hansch, C., The role of hydrophobic properties of chemicals in promoting allosteric reactions, Bioorg. Med. Chem., 13, 3737, 2005.
18. Prasanna, S., Manivannan, E., and Chaturvedi, S.C., QSAR studies on structurally similar 2-(4-methanesulfonylphenyl)pyran-4-ones as selective COX-2 inhibitors: a Hansch approach, Bioorg. Med. Chem. Lett., 15, 313, 2005.
19. Brown, T.M. and Bryson, P.K., Selective inhibitors of methyl parathion-resistant acetylcholinesterase from Heliothis virescens, Pestic. Biochem. Physiol., 44, 155, 1992.
20. Daly, A.K., Pharmacogenetics of the major polymorphic metabolizing enzymes, Fundam. Clin. Pharmacol., 17, 27, 2003.
21. Dickinson, D.A. and Forman, H.J., Cellular glutathione and thiols metabolism, Biochem. Pharmacol., 64, 1019, 2002.
22. Gerhold, D., Lu, M., Xu, J., Austin, C., Caskey, C.T., and Rushmore, T., Monitoring expression of genes involved in drug metabolism and toxicology using DNA microarrays, Physiol. Genomics, 5, 161, 2001.
23. Grothesen, J.R. and Brown, T.M., Stereoselectivity of acetylcholinesterase, arylester hydrolase and chymotrypsin toward 4-nitrophenyl alkyl(phenyl)phosphinates, Pestic. Biochem. Physiol., 26, 100, 1986.
24. Hodgson, E. and Goldstein, J.A., Metabolism of toxicants: phase I reactions and pharmacogenetics, in Introduction to Biochemical Toxicology, Hodgson, E. and Smart, R.C., Eds., Elsevier, New York, 2001, chap. 5.
25. LeBlanc, G.A. and Dauterman, W.C., Conjugation and elimination of toxicants, in Introduction to Biochemical Toxicology, Hodgson, E. and Smart, R.C., Eds., Elsevier, New York, 2001, chap. 6.
26. Matsumura, F., Toxicology of Insecticides, Plenum Press, New York, 1984.
27. Nebert, D.W. and Gonzalez, F.J., P450 genes: structure, evolution and regulation, Annu. Rev. Biochem., 56, 945, 1987.
28. Nebert, D.W. and Nelson, D.R., p450 gene nomenclature based on evolution, in Cytochrome P450, Waterman, M.R. and Johnson, E.F., Eds., Academic Press, San Diego, CA, 1991, p. 3.
29. Parkinson, A., Biotransformation of xenobiotics, in Casarett and Doull’s Toxicology, Klaassen, C.D., Ed., McGraw-Hill, New York, 2001, chap. 6.
30. Ravichandran, K.G., Boddupalli, S.S., Hasemann, C.A., Peterson, J.A., and Deisenhofer, J., Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450s, Science, 261, 731, 1993.
31. Sussman, J.L., Harel, M., and Frolow, F., Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein, Science, 253, 872, 1991.
32. Wislocki, P.G., Miwa, G.T., and Lu, A.Y.H., Reactions catalyzed by P450, in Enzymatic Basis of Detoxication, Jacoby, Ed., Academic Press, New York, 1981, pp. 135–182.
33. Antonsson, B. and Martinou, J.-C., The Bcl-2 protein family, Exp. Cell Res., 256, 50, 2000.
34. Chandrasekharan, N.V., Dai, H., Lamar Turepu Roos, K., Evanson, N.K., Tomsik, J., Elton, T.S., and Simmons, D.L., COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression, Proc. Natl. Acad. Sci. U.S.A., 99, 13926, 2002.
35. Danial, N.N. and Korsmeyer, S.J., Cell death: critical control points, Cell, 116, 205, 2004.
36. Ecobichon, D.J., Toxic effects of pesticides, in Casarett and Doull’s Toxicology, Klaassen, C.D., Ed., McGraw-Hill, New York, 2001, chap. 22.
37. FitzGerald, G.A., Coxibs and cardiovascular disease, N. Engl. J. Med., 351, 1709, 2004.
38. Green, D.R. and Kroemer, G., The pathophysiology of mitochondrial cell death, Science, 305, 626, 2004.
39. Gregus, Z. and Klaassen, C.D., Mechanisms of toxicity, in Casarett and Doull’s Toxicology, Klaassen, C.D., Ed., McGraw-Hill, New York, 2001, chap. 3.
40. Hata, A.N. and Breyer, R.M., Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation, Pharmacol. Ther., 103, 147, 2004.
41. Hendrick, J.P. and Hartl, F.-U., Molecular chaperone functions of heat-shock proteins, Annu. Rev. Biochem., 62, 349, 1993.
42. Herman, B., Gores, G.J., Nieminen, A.-L., Kawanishi, T., Harman, A., and Lemasters, J.J., Calcium and pH in anoxic and toxic injury, CRC Crit. Rev. Toxicol., 21, 127, 1990.
43. Juni, P., Nartey, L., Reichenbach, S., Sterchi, R., Dieppe, P.A., and Egger, M., Risk of cardiovascular events and rofecoxib: cumulative meta-analysis, Lancet, 364, 2021, 2004.
44. Lemasters, J.J., Nieminen, A.-L., Qian, T., Trost, L.C., Elmore, S.P., Nishimura, Y., Crowe, R.A., Cascio, W.E., Bradham, C.A., Brenner, D.A., and Herman, B., The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy, Biochim. Biophys. Acta, 1366(1-2), 177, 1998.
45. Lemasters, J.J., Qian, T., Bradham, C.A., Brenner, D.A., Cascio, W.E., Trost, L.C., Nishimura, Y., Nieminen, A.-L., and Herman, B., Mitochondrial dysfunction in the pathogenesis of necrotic and apoptotic cell death, J. Bioenerg. Biomembranes, 31(4), 305, 1999.
46. Moreland, D.E., Effects of toxicants on electron transport and oxidative phosphorylation, in Introduction to Biochemical Toxicology, Hodgson, E. and Smart, R.C., Eds., Elsevier, New York, 2001, chap. 13.
47. Morimoto, R.I., Kline, M.P., Bimston, D.N., and Cotto, J.J., The heat shock response: regulation and function of heat-shock proteins and molecular chaperones, Essays Biochem., 32, 17, 1997.
48. Moseley, P.L., Heat shock proteins and heat adaptation of the whole organism, J. Appl. Physiol., 83(5), 1413, 1997.
49. Robertson, J.D. and Orrenius, S., Role of mitochondria in toxic cell death, Toxicology, 181/182, 491, 2002.
50. Vane, J.R. and Botting, R.M., The mechanism of action of aspirin, Thrombosis Res., 110, 255, 2003.
51. Zoratti, M. and Szabo, I., The mitochondrial permeability transition, Biochim. Biophys. Acta, 1241(2), 139, 1995.
52. Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., and Walter, P., Molecular Biology of the Cell, Garland Science, New York, 2002.
53. Altschul, S.F., Madden, T.L., Schäffer, A.A., Zhang, J., Zhang, Z., Miller, W., and Lipman, D.J., Gapped BLAST and PSI-BLAST: a new generation of protein database search programs, Nucleic Acids Res., 25, 3389, 1997.
54. Burczynski, M.E., Ed., An Introduction to Toxicogenomics, CRC Press, Boca Raton, FL, 2003.
55. Gasteiger, E., Gattiker, A., Hoogland, C., Ivanyi, I., Appel, R.D., and Bairoch, A., ExPASy: the proteomics server for in-depth protein knowledge and analysis, Nucleic Acids Res., 31, 3784, 2003.
56. Gibson, G. and Muse, S.V., A Primer of Genome Science, Sinauer Associates, Sunderland, MA, 2002.
57. Holmes, E., Nicholls, A.W., Lindon, J.C., Connor, S.C., Connelly, J.C., Haselden, J.N., Damment, S.J.P., Spraul, M., Neidig, P., and Nicholson, J.K., Chemometric models for toxicity classification based on NMR spectra of biofluids, Chem. Res. Toxicol., 13, 471, 2000.
58. The International HapMap Consortium, A haplotype map of the human genome, Nature, 437, 1299, 2005.
59. Ioannidis, J.P., Ntzani, E., and Trikalinos, T.A., “Racial” differences in genetic effects for complex diseases, Nat. Genet., 36, 1312, 2004.
60. Lorkowski, S. and Cullen, P., Analyzing Gene Expression. A Handbook of Methods: Possibilities and Pitfalls, Wiley-VCH Verlag GmbH & Co., Weinheim, Germany, 2003.
61. Marshall, A., Taroncher-Oldenburg, G., Aschheim, K., DeFrancesco, L., and Cervoni, N., Focus on systems biology, Nat. Biotechnol., 22, 10, 2004.
62. National Human Genome Center, Genetics for the human race, Nat. Genet., 36 (Suppl.), 60, 2004.
63. Paabo, S., The mosaic that is our genome, Nature, 421, 409, 2003.
64. Parra, E.J., Kittles, R.A., and Shriver, M.D., Implications of correlations between skin color and genetic ancestry for biomedical research, Nat. Genet., 36, 11, S54.
65. Taulan, M., Paquet, F., Maubert, C., Delissen, O., Jacques Demaille, J., and Romey, M.C., Renal toxicogenomic response to chronic uranyl nitrate insult in mice, Environ. Health Perspect., 112, 1628, 2004.
66. Venter, J.C., Adams, M.D., Myers, E.W., Li, P.W., Mural, R.J., Sutton, G.G., Smith, H.O., Yandell, M., Evans, C.A., Holt, R.A., et al., The sequence of the human genome, Science, 291, 1304, 2001.
67. Waters, M.D. and Fostel, J.M., Toxicogenomics and systems toxicology: aims and prospects, Nat. Rev. Genet., 5, 936, 2004.
68. Williams, D.P., Garcia-Allan, C., Hanton, G., LeNet, J.L., Provost, J.P., Brain, P., Walsh, R., Johnston, G.I., Smith, D.A., and Park, B.K., Time course toxicogenomic profiles in CD-1 mice after nontoxic and nonlethal hepatotoxic paracetamol administration, Chem. Res. Toxicol., 17, 1551, 2004.
69. Aaronson, S.A., Growth factors and cancer, Science, 254, 1146, 1991.
70. Balmain, A. and Brown, K., Oncogene activation in chemical carcinogenesis, Adv. Cancer Res., 51, 147, 1988.
71. Bock, G. and Marsh, J., Proto-oncogenes in Cell Development, John Wiley & Sons, Chichester, U.K., 1990, p. 295.
72. Boguski, M.S., Bairoch, A., Attwood, T.K., and Michaels, G.S., Proto-vav and gene expression, Nature, 358, 113, 1992.
73. Bourne, H.R. and Stryer, L., G proteins: the target sets the tempo, Nature, 358, 541, 1992.
74. Choueiri, T.K., Alemany, C.A., Abou-Jawde, R.M., and Budd, G.T., Role of aromatase inhibitors in the treatment of breast cancer, Clin. Ther., 26, 8, 1199, 2004.
75. Cohen, S.M. and Ellwein, L.B., Cell proliferation in carcinogenesis, Science, 249, 1007, 1990.
76. Cuperlovic-Culf, M., Belacel, N., and Ouellette, R.J., Determination of tumor marker genes from gene expression data, Drug Discovery Today, 10, 6, 429, 2005.
77. Downward, J., Signal transduction: Rac and Rho in tune, Nature, 359, 273, 1992.
78. Duesberg, P. and Rasnick, D., Aneuploidy, the somatic mutation that makes cancer a species of its own, Cell Motility Cytoskel., 47, 81, 2000.
79. Farmer, G., Bargonetti, J., Zhu, H., Friedman, P., Prywes, R., and Prives, C., Wild-type p53 activates transcription in vitro, Nature, 358, 83, 1992.
80. Franke, R. and Gruska, A., General introduction to QSAR, in Quantitative Structure-Activity Relationship (QSAR) Models of Mutagens and Carcinogens, Benigni, R., Ed., CRC Press, Boca Raton, FL, 2003.
81. Grimm, D., Disease backs cancer origin theory, Science, 306, 389, 2004.
82. Gupta, P.B., Kuperwasser, C., Brunet, J.P., Ramaswamy, S., Kuo, W.L., Gray, J.W., Naber, S.P., and Weinberg, R.A., The melanocyte differentiation program predisposes to metastasis after neoplastic transformation, Nat. Genet., 37, 1047, 2005.
83. Harlow, E., Retinoblastoma: for our eyes only, Nature, 359, 270, 1992.
84. Harris, C.C. and Liotta, L.A., Genetic Mechanisms in Carcinogenesis and Tumor Progression, John Wiley & Sons, New York, 1990, p. 235.
85. Hausen, H. zur, Viruses in human cancers, Science, 254, 1167, 1991.
86. Hemminki, K., Rawal, R., Chen, B., and Bermejo, J.L., Genetic epidemiology of cancer: from families to heritable genes, Int. J. Cancer, 111, 944, 2004.
87. Kaplan, D.R., Hempstead, B.L., Martin-Zanca, D., Chao, M.V., and Parada, L.F., The trk proto-oncogene product: a signal tranducing receptor for nerve growth factor, Science, 252, 554, 1991.
88. Kurzrock, R., Kantarjian, H.M., Druker, B.J., and Talpaz, M., Philadelphia chromosome-positive leukemias: from basic mechanisms to molecular therapeutics, Ann. Intern. Med., 138, 819, 2003.
89. Lane, D.P., Cancer: p53, guardian of the genome, Nature, 358, 15, 1992.
90. Leaf, C., The war on cancer, why we’re losing the war on cancer — and how to win it, Fortune, March 22, 2004.
91. Li, R., Yerganian, G., Duesberg, P., Kraemer, A., Willer, A., Rausch, C., and Hehlmann, R., Aneuploidy correlated 100% with chemical transformation of Chinese hamster cells, Proc. Natl. Acad. Sci. U.S.A., 94, 14506, 1997.
92. Lichtner, R.B., Estrogen/EGF receptor interactions in breast cancer: rationale for new therapeutic combination strategies, Biomed. Pharmacother., 57, 447, 2003.
93. Loktionov, A., Common gene polymorphisms, cancer progression and prognosis, Cancer Lett., 208, 1, 2004.
94. Marsh, D.J. and Zori, R.T., Genetic insights into familial cancers: update and recent discoveries, Cancer Lett., 181, 125, 2002.
95. Oliner, J.D., Kinzler, K.W., Meltzer, P.S., George, D.L., and Vogelstein, B., Amplification of a gene encoding a p53-associated protein in human sarcomas, Nature, 358, 80, 1992.
96. Pavletich, N.P. and Pabo, C.O., Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex at 2.1 Å, Science, 252, 809, 1991.
97. Petsko, G.A., Signal transduction: fishing in Src-infested waters, Nature, 358, 625, 1992.
98. Pitot, H.C., III, and Dragan, Y.P., Chemical carcinogenesis, in Casarett and Doull’s Toxicology, Klaassen, C.D., Ed., McGraw-Hill, New York, 2001, chap. 8.
99. Plass, C., Cancer epigenomics, Hum. Mol. Genet., 11, 2479, 2002.
100. Powell, S.M., Zilz, N., Beazer-Barclay, Y., Bryan, T.M., Hamilton, S.R., Thibodeau, S.N., Vogelstein, B., and Kinzler, K.W., APC mutations occur early during colorectal tumorigenesis, Nature, 359, 235, 1992.
101. Prehn, R.T., The role of mutation in the new cancer paradigm, Cancer Cell Int., 5, 9, 2005.
102. Preston, R.J. and Hoffmann, G.R., Genetic toxicology, in Casarett and Doull’s Toxicology, Klaassen, C.D., Ed., McGraw-Hill, New York, 2001, chap. 9.
103. Roberts, L., More pieces in the dioxin puzzle, Science, 254, 377, 1991.
104. Saglio, G. and Cilloni, D., Abl: the prototype of oncogenic fusion proteins, Cell. Mol. Life Sci., 61, 2897, 2004.
105. Schneider, G. and So, S.-S., Adaptive Systems in Drug Design, Landes Bioscience, Georgetown, TX, 2002.
106. Simon, M.I., Strathmann, M.P., and Gautam, N., Diversity of G proteins in signal transduction, Science, 252, 802, 1991.
107. Solomon, E., Colorectal cancer genes, Nature, 343, 412, 1990.
108. Solomon, E., Borrow, J., and Goddard, A.D., Chromosome aberrations and cancer, Science, 254, 1153, 1991.
109. Waisberg, M., Joseph, P., Hale, B., and Beyersmann, D., Molecular and cellular mechanisms of cadmium carcinogenesis, Toxicology, 192, 95, 2003.
110. Waksman, G., Kominos, D., Robertson, S.C., Pant, N., and Baltimore, D., Crystal structure of the phosphotyrosine recognition domain SH2 of V-src complexed with tyrosine-phosphorylated peptides, Nature, 358, 646, 1992.
111. Beckman, D.A. and Feuston, M., Landmarks in the development of the female reproductive system, Birth Defects Res. B, 68, 137, 2003.
112. Carlson, E., Giwercman, A., Keiding, N., and Skakkebaek, N.E., Evidence for decreasing quality of semen during the past 50 years, BMJ, 305, 609, 1992.
113. Christian, M.S., Test methods for assessing female reproductive and developmental toxicology, in Principles and Methods in Toxicology, Hayes, A.W., Ed., Taylor & Francis, Philadelphia, 2001, chap. 29.
114. Claudio, L., Bearer, C.F., and Wallinga, D., Assessment of the U.S. Environmental Protection Agency Methods for Identification of Hazards to Developing Organisms. Part I. The reproduction and fertility testing guidelines, Am. J. Ind. Med., 35, 543, 1999.
115. Claudio, L., Bearer, C.F., and Wallinga, D., Assessment of the U.S. Environmental Protection Agency Methods for Identification of Hazards to Developing Organisms. Part II. The developmental toxicity testing guideline, Am. J. Ind. Med., 35, 554, 1999.
116. Clegg, E.D., Perreault, S.D., and Klinefelter, G.R., Assessment of male reproductive toxicity, in Principles and Methods in Toxicology, Hayes, A.W., Ed., Taylor & Francis, Philadelphia, 2001, chap. 28.
117. Collins, T.F.X., Current protocols in teratology and reproduction, in Safety Evaluation of Drugs and Chemicals, Lloyd, W.E., Ed., Hemisphere Publishing Corporation, Washington, D.C., 1986, chap. 13.
118. Daston, G.P., Cook, J.C., and Kavlock, R.J., Uncertainties for endocrine disrupters: our view on progress, Toxicol. Sci., 74, 245, 2003.
119. Dimopoulos, M.A. and Eleutherakis-Papaiakovou, V., Adverse effects of thalidomide administration in patients with neoplastic diseases, Am. J. Med., 117, 508, 2004.
120. Franks, M.E., Macpherson, G.R., and Figg, W.D., Thalidomide, Lancet, 363, 1802, 2004.
121. Johnson, J., Canning, J., Kaneko, T., Pru, J.K., and Tilly, J.L., Germline stem cells and follicular renewal in the postnatal mammalian ovary, Nature, 428, 145, 2004.
122. Kalter, H., Teratology in the 20th century. Environmental causes of congenital malformations in humans and how they were established, Neurotoxicol. Teratol., 25, 131, 2003.
123. Loose-Mitchell, D.S. and Stancel, G.M., Estrogens and progestins, in Goodman and Gilman’s: The Pharmacological Basis of Therapeutics, Hardman, J.G. and Limbird, L.E., Eds., McGraw-Hill, New York, 2001, chap. 58.
124. Mangelsdorf, I., Buschmann, J., and Orthen, B., Some aspects relating to the evaluation of the effects of chemicals on male fertility, Regul. Toxicol. Pharmacol., 37, 356, 2003.
125. Marty, M.S., Chapin, R.E., Parks, L.G., and Thorsrud, B.A., Development and maturation of the male reproductive system, Birth Defects Res. B, 68, 125, 2003.
126. McKinnell, R.G. and Di Berardino, M.A., The biology of cloning: history and rationale, Bioscience, 49, 11, 1999.
127. Miller, R.K., Perinatal toxicology: its recognition and fundamentals, Am. J. Ind. Med., 4, 205, 1983.
128. Miller, R.K., Kellogg, C.K., and Saltzman, R.A., Reproductive and perinatal toxicology, in Handbook of Toxicology, Haley, T.J. and Berndt, W.O., Eds., Hemisphere Publishing Corporation, Washington, D.C., 1987, chap. 7.
129. Radike, M., Reproductive toxicology, in Industrial Toxicology, Williams, P.L. and Burson, J.L., Eds., Van Nostrand Reinhold Company, New York, 1985, chap. 16.
130. Rideout, W.M., III, Eggan, K., and Jaenisch, R., Nuclear cloning and epigenetic reprogramming of the genome, Science, 293, 5532, 2001.
131. Rogers, J.M. and Kavlock, R.J., Developmental toxicology, in Casarett and Doull’s Toxicology, Klaassen, C.D., Ed., McGraw-Hill, New York, 2001, chap. 10.
132. Safe, S., Endocrine disruptors and human health: is there a problem?, Toxicology, 205, 3, 2004.
133. Snyder, P.J., Androgens, in Goodman and Gilman’s: The Pharmacological Basis of Therapeutics, Hardman, J.G. and Limbird, L.E., Eds., McGraw-Hill, New York, 2001, chap. 59.
134. Thomas, M.J. and Thomas, J.A., Toxic responses of the reproductive system, in Casarett and Doull’s Toxicology, Klaassen, C.D., Ed., McGraw-Hill, New York, 2001, chap. 20.
135. Whorton, M.D., Bedinghaus, J., Obrinsky, D., and Spear, P.W., Reproductive disorders, in Occupational Health, Levy, B.S. and Wegman, D.H., Eds., Little, Brown, & Company, Boston, 1983, chap. 20.
136. Wilmut, I., Beaujean, N., de Sousa, P.A., Dinnyes, A., King, T.J., Paterson, L.A., Wells, D.N., and Young, L.E., Somatic cell nuclear transfer, Nature, 419, 583, 2002.
137. Armstrong, B., Hutchinson, E., Unwin, J., and Fletcher, T., Lung cancer risk after exposure to polycyclic aromatic hydrocarbons: a review and meta-analysis, Environ. Health Perspect., 112, 9, 2004.
138. Barnes, P.J., Chronic obstructive pulmonary disease, N. Engl. J. Med., 343, 4, 269, 2000.
139. Belvisi, M.G. and Bottomley, K.M., The role of matrix metalloproteinases (MMPs) in the pathophysiology of chronic obstructive pulmonary disease (COPD): a therapeutic role for inhibitors of MMPs?, Inflammation Res., 52, 95, 2003.
140. Henderson, R.F. and Nikula, K.J., Respiratory tract toxicity, in Introduction to Biochemical Toxicology, Hodgson, E. and Smart, R.C., Eds., Elsevier, New York, 2001, chap. 24.
141. Hoffmann, D. and Hoffmann, I., The changing cigarette: chemical studies and bioassays, in Risks Associated with Smoking Cigarettes with Low Tar Machine-Measured Yields of Tar and Nicotine, Smoking and Tobacco Control Monograph 13, U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, 2001.
142. Hogg, J.C., Pathophysiology of airflow limitation in chronic obstructive pulmonary disease, Lancet, 364, 709, 2004.
143. Li, N., Hao, M., Phalen, R.F., Hinds, W.C., and Nel, A.E., Particulate air pollutants and asthma. A paradigm for the role of oxidative stress in PM-induced adverse health effects, Clin. Immunol., 109, 250, 2003.
144. Manning, C.B., Vallyathan, V., and Mossman, B.T., Diseases caused by asbestos: mechanisms of injury and disease development, Int. Immunopharmacol., 2, 191, 2002.
145. Mannino, D.M., COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity, Chest, 121, 5, 121S, 2002.
146. Marshall, E., Involuntary smokers face health risks, Science, 234, 1066, 1986.
147. National Library of Medicine, Hazardous Substances Data Bank, available at http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB.
148. Reasor, M.J., The composition and dynamics of environmental tobacco smoke, J. Environ. Health, 50, 20, 1987.
149. Valentine, R. and Kennedy, G.L., Inhalation toxicology, in Principles and Methods of Toxicology, 4th ed., Hayes, A.W., Ed., Taylor & Francis, Philadelphia, 2001.
150. Witschi, H.R. and Last, J.A., Toxic responses of the respiratory system, in Casarett and Doull’s Toxicology, Klaassen, C.D., Ed., McGraw-Hill, New York, 2001, chap. 15.
151. Zeidler, P.C. and Castranova, V., Role of nitric oxide in pathological responses of the lung to exposure to environmental/occupational agents, Redox Rep., 9, 1, 7, 2004.
152. Bloom, J.C. and Brandt, J.T., Toxic responses of the blood, in Casarett and Doull’s Toxicology, Klaassen, C.D., Ed., McGraw-Hill, New York, 2001, chap. 11.
153. Combs, A.B., Ramos, K., and Acosta, D., Cardiovascular toxicity, in Introduction to Biochemical Toxicology, Hodgson, E. and Smart, R.C., Eds., Elsevier, New York, 2001, chap. 26.
154. Gorman, D., Drewry, A., Huang, Y.L., and Sames, C., The clinical toxicology of carbon monoxide, Toxicology, 187, 25, 2003.
155. James, R.C., Hematotoxicity: toxic effects in the blood, in Industrial Toxicology, Williams, P.L. and Burson, J.L., Eds., Van Nostrand Reinhold, New York, 1985, chap. 4.
156. Lang, C.H., Kimball, S.R., Frost, R.A., and Vary, T.C., Alcohol myopathy: impairment of protein synthesis and translation initiation, Int. J. Biochem. Cell Biol., 33, 457, 2003.
157. Lewis, W., Cardiomyopathy, nucleoside reverse transcriptase inhibitors and mitochondria are linked through AIDS and its therapy, Mitochondrion, 4, 141, 2004.
158. Logue, S.E., Gustafsson, A.B., Samali, A., and Gottleib, R.A., Ischemia/reperfusion injury at the intersection with cell death, J. Mol. Cell. Cardiol., 38, 21, 2005.
159. Ramos, K.S., Melchert, R.B., Chacon, E., and Acosta, D., Jr., Toxic responses of the heart and vascular systems, in Casarett and Doull’s Toxicology, Klaassen, C.D., Ed., McGraw-Hill, New York, 2001, chap. 18.
160. Smith, T.L., Koman, L.A., Mosberg, A.T., and Hayes, A.W., Cardiovascular physiology and methods for toxicology, in Principles and Methods of Toxicology, 4th ed., Hayes, A.W., Ed., Taylor & Francis, Philadelphia, 2001, chap. 27.
161. Van Stee, E.W., Cardiovascular toxicology: foundations and scope, in Cardiovascular Toxicology, VanStee, E.W., Ed., Raven Press, New York, 1982.
162. Wallace, K.B., Doxorubicin-induced cardiac mitochondrionopathy, Pharmacol. Toxicol., 93, 105, 2003.
163. Aarts, M.M. and Tymianski, M., Novel treatment of excitotoxicity: targeted disruption of intracellular signaling from glutamate receptors, Biochem. Pharmacol., 66, 877, 2003.
164. Anthony, D.C., Montine, T.J., Valentine, W.M., and Graham, D.G., Toxic responses of the nervous system, in Casarett and Doull’s Toxicology, Klaassen, C.D., Ed., McGraw-Hill, New York, 2001, chap. 16.
165. Arnon, S.S., Schechter, R., Inglesby, T.V., Henderson, D.A., Bartlett, J.G., Ascher, M.S., Eitzen, E., Fine, A.D., Hauer, J., Layton, M.K., Lillibridge, S., Osterholm, M.T., O’Toole, T., Parker, G., Perl, T.M., Russell, P.K., Swerdlow, D.L., and Tonat, K., Botulinum toxin as a biological weapon, JAMA, 285, 8, 2001.
166. Arundine, M. and Tymianski, M., Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury, Cell. Mol. Life Sci., 61, 657, 2004.
167. Asbury, A.K. and Brown, M.J., The evolution of structural changes in distal axonopathies, in Exp. Clin. Neurotoxicol., Spencer, P.S. and Schaumburg, H.H., Eds., Williams & Wilkins, Baltimore, 1980, chap. 12.
168. Banack, S.A. and Cox, P.A., Biomagnification of cycad neurotoxins in flying foxes: implications for ALS-PDC in Guam, Neurology, 61, 387, 2003.
169. Blumenfeld, A., Botulinum toxin type A for the treatment of headache: pro, Headache, 44, 825, 2004.
170. Brown, A.W., Aldridge, W.N., Street, B.W., and Verschoyle, R.D., The behavioral and neuropathologic sequelae of intoxication by trimethyltin compounds in the rat, Am. J. Pathol., 97, 59, 1979.
171. Caya, J.G., Agni, R., and Miller, J.E., Clostridium botulinum and the clinical laboratorian, Arch. Pathol. Lab. Med., 128, 653, 2004.
172. Comella, C.L. and Pullman, S.L., Botulinum toxins in neurological disease, Muscle Nerve, 29, 628, 2004.
173. Engelhardt, B., Development of the blood-brain barrier, Cell Tissue Res., 314, 119, 2003.
174. Griffin, J.W. and Price, D.L., Proximal axonopathies induced by toxic chemicals, in Experimental and Clinical Neurotoxicology, Spencer, P.S. and Schaumburg, H.H., Eds., Williams & Wilkins, Baltimore, 1980, chap. 11.
175. Gunawardena, S.l. and Goldstein, L.S.B., Cargo-carrying motor vehicles on the neuronal highway: transport pathways and neurodegenerative disease, J. Neurobiol., 58, 258, 2004.
176. Lee, D., Park, Y., Brown, T.M., and Adams, M.E., Altered properties of neuronal sodium channels associated with genetic resistance to pyrethroids, Mol. Pharm., 55, 584, 1999.
177. Lewin, R., Parkinson’s disease: an environmental cause?, Science, 229, 257, 1985.
178. Li, S.-H. and Li, X.-J., Huntingtin-protein interactions and the pathogenesis of Huntington’s disease, Trends Genet., 20, 146, 2004.
179. Lowndes, H.E. and Baker, T., Toxic site of action in distal axonopathies, in Experimental and Clinical Neurotoxicology, Spencer, P.S. and Schaumburg, H.H., Eds., Williams & Wilkins, Baltimore, 1980, chap. 13.
180. Marchi, N., Cavaglia, M., Fazio, V., Bhudia, S., Hallene, K., and Janigro, D., Peripheral markers of blood-brain barrier damage, Clin. Chim. Acta, 342, 1, 2004.
181. Miller, C.C.J., Ackerley, S., Brownlees, J., Grierson, A.J., Jacobsen, N.J.O., and Thornhill, P., Axonal transport of neurofilaments in normal and disease states, Cell. Mol. Life Sci., 59, 323, 2002.
182. Nelson, R.M., Lambert, D.G., Green, A.R., and Hainsworth, A.H., Pharmacology of ischemia-induced glutamate efflux from rat cerebral cortex in vitro, Brain Res., 964, 1, 2003.
183. Nicotera, P., Molecular switches deciding the death of injured neurons, Toxicol. Sci., 74, 4, 2003.
184. Pope, C., Karanth, S., and Liu, J., Pharmacology and toxicology of cholinesterase inhibitors: uses and misuses of a common mechanism of action, Environ. Toxicol. Pharmacol., 19, 433, 2005.
185. Schober, A., Classic toxin-induced animal models of Parkinson’s disease: 6-OHDA and MPTP, Cell Tissue Res., 318, 215, 2004.
186. Snyder, S.H., Opiate receptors and beyond: 30 years of neural signaling research, Neuropharmacology, 47, 274, 2004.
187. Sotgiu, S., Pugliatti, M., Fois, J.L., Arru, G., Sanna, A., Sotgiu, M.A., and Rosati, G., Genes, environment, and susceptibility to multiple sclerosis, Neurobiol. Dis., 17, 131, 2004.
188. Stokin, G.B., Lillo, C., Falzone, T.L., Brusch, R.G., Rockenstein, E., Mount, S.L., Raman, R., Davies, P., Masliah, E., Williams, D.S., and Goldstein, L.S.B., Axonopathy and transport deficits early in the pathogenesis of Alzheimer’s disease, Science, 307, 1282, 2005.
189. Weiss, B. and Cory-Slechta, D.A., Assessment of beharioral toxicity, in Principles and Methods of Toxicology, 4th ed., Hayes, A.W., Ed., Taylor & Francis, Philadelphia, 2001.
190. Williamson, M.S., Martinez-Torres, D., Hick, C.A., Castells, N., and Devonshire, A.L., Analysis of sodium channel gene sequences in pyrethroid-resistant houseflies, in Molecular Genetics and Evolution of Pesticide Resistance, ACS Symposium Series, Vol. 645, Brown, T.M., Ed., American Chemical Society Books, Washington, D.C., 1996.
191. Winrow, C.J., Hemming, M.L., Allen, D.M., Quistad, G.B., Casica, J.E., and Barlow, C., Loss of neuropathy target esterase in mice links organophosphate exposure to hyperactivity, Nat. Genet., 33, 477, 2003.
192. Yamada, M. and Hasuhara, H., Clinical pharmacology of MAO inhibitors: safety and future, Neurotoxicology, 25, 215, 2004.
193. Belat, E.D., Bresee, J.S., Holman, R.C., Khan, A.S., Shahriari, A., and Schonberger, L.B., Reye’s syndrome in the United States from 1981 through 1997, N. Engl. J. Med., 340, 1377, 1999.
194. Browning, J.D. and Horton, J.D., Molecular mediators of hepatic steatosis and liver injury, J. Clin. Invest., 114, 147, 2004.
195. Fausto, N. and Campbell, J.S., The role of hepatocytes and oval cells in liver regeneration and repopulation, Mechanisms Dev., 120, 117, 2003.
196. Felipo, V. and Butterworth, R.F., Mitochondrial dysfunction in acute hyperammonemia, Neurochem. Int., 40, 487, 2002.
197. Greenberg, D.A., The jaundice of the cell, Proc. Natl. Acad. Sci. U.S.A., 99, 15837, 2002.
198. Ishii, H., Common pathogenic mechanisms in ASH and NASH, Hepatol. Res., 28, 18, 2004.
199. Jaeschke, H., Gores, G.J., Cederbaum, A.I., Hinson, J.A., Pessayre, D., and Lemasters, J.J., Mechanisms of hepatotoxicity, Toxicol. Sci., 65, 166, 2002.
200. Jaeschke, H., Gujral, J.S., and Bajt, M.L., Apoptosis and necrosis in liver disease, Liver Int., 24, 85, 2004.
201. Kirschstein, R. and Skirboll, L.R., Stem Cells: Scientific Progress and Future Research Directions, NIH, 2001, available at http://stemcells.nih.gov/info/scireport/.
202. Meyer, S.A. and Kulkarni, A.P., Hepatotoxicity, in Introduction to Biochemical Toxicology, Hodgson, E. and Guthrie, F.E., Eds., Wiley Interscience, New York, 2001, chap. 20.
203. Parkinson, A., Biotransformation of toxicants, in Casarett and Doull’s Toxicology, Klaassen, C.D., Ed., McGraw-Hill, New York, 2001, chap. 6.
204. Plaa, G.L. and Charbonneau, M., Detection and evaluation of chemically induced liver injury, in Principles and Methods of Toxicology, Hayes, A.W., Ed., Taylor & Francis, Philadelphia, 2001, chap. 24.
205. Reye, R.D.K., Morgan, G., and Baral, J., Encephalopathy and fatty degeneration of the viscera. A disease entity in childhood, Lancet, 2, 749, 1963.
206. Rockey, D.C. and Shah, V., Nitric oxide biology and the liver: report of an AASLD research workshop, Hepatology, 39, 250, 2004.
207. Rumack, B.H., Acetaminophen hepatotoxicity: the first 35 years, Clin. Toxicol., 40, 3, 2002.
208. Treinen-Moslen, M., Toxic responses of the liver, in Casarett and Doull’s Toxicology, Klaassen, C.D., Ed., McGraw-Hill, New York, 2001, chap. 13.
209. Trost, L.C. and Lemasters, J.J., Role of the mitochondrial permeability transition in salicylate toxicity to cultured rat hepatocytes: implications for the pathogenesis of Reye’s syndrome, Toxicol. Appl. Pharmacol., 147, 431, 1997.
210. Wang, J.-S. and Groopman, J.D., Hepatic disorders, in Occupational Health, Levy, B.S. and Wegman, D.H., Eds., Lippincott, Williams & Wilkins, Baltimore, 2000, chap. 34.
211. Amin, R.P., Vickers, A.E., Sistare, F., Thompson, K.L., Roman, R.J., Lawton, M., Kramer, J., Hamadeh, H.K., Collins, J., Grissom, S., Bennett, L., Tucker, C.J., Wild, S., Kind, C., Oreffo, V., Davis, J.W., II, Curtiss, S., Naciff, J.M., Cunningham, M., Tennant, R., Stevens, J., Car, B., Bertram, T.A., and Afshari, C.A., Identification of putative gene-based markers of renal toxicity, Environ. Health Perspect., 112, 4, 2004.
212. Berndt, W.O., Use of the tissue slice technique for evaluation of renal transport processes, Environ. Health Perspect., 15, 73, 1976.
213. Berndt, W.O., Effects of toxic chemicals on renal transport processes, Fed. Proc., 38, 2226, 1979.
214. Davis, M.E. and Berndt, W.O., Renal methods for toxicology, in Principles and Methods in Toxicology, Hayes, A.W., Ed., Taylor & Francis, Philadelphia, 2001, chap. 25.
215. Guan, N., Ding, J., Deng, J., Zhang, J., and Yang, J., Key molecular events in puromycin aminonucleoside nephrosis in rats, Pathol. Int., 54, 703, 2004.
216. Kohn, S., Fradis, M., Ben-David, J., Zidan, J., and Robinson, E., Nephrotoxicity of combined treatment with cisplatin and gentamicin in the guinea pig: glomerular injury findings, Ultrastruct. Pathol., 26, 371, 2002.
217. Middendorf, P.J. and Williams, P.L., Nephrotoxicity: toxic responses of the kidney, in Principles of Toxicology: Environmental and Industrial Applications, Williams, P.L., James, R.C., and Roberts, S.M., Eds., John Wiley & Sons, New York, 2000.
218. Roch-Ramel, F. and Peters, G., Micropuncture techniques as a tool in renal pharmacology, Annu. Rev. Pharmacol. Toxicol., 19, 323, 1979.
219. Schnellman, R.G., Toxic responses of the kidney, in Casarett and Doull’s Toxicology, Klaassen, C.D., Ed., McGraw-Hill, New York, 2001, chap. 14.
220. Aronoff, D.M. and Neilson, E.G., Antipyretics: mechanisms of action and clinical use in fever suppression, Am. J. Med., 111, 304, 2001.
221. Bircher, A.J., Symptoms and danger signs in acute drug hypersensitivity, Toxicology, 209, 201, 2005.
222. Blanca, M., Cornejo-Garcia, J.A., Torres, M.J., and Mayorga, C., Specificities of B cell reactions to drugs. The penicillin model, Toxicology, 209, 181, 2005.
223. Burns-Naas, L.A., Meade, B.J., and Munson, A.E., Toxic responses of the immune system, in Casarett and Doull’s Toxicology, Klaassen, C.D., Ed., McGraw-Hill, New York, 2001, chap. 12.
224. Dinarello, C.A., Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed, J. Endotoxin Res., 10, 4, 2004.
225. Emini, E.A. and Fan, H.Y., Immunological and pharmacological approaches to the control of retroviral infections, in Retroviruses, Coffin, J.M., Hughes, S.H., and Varmus, H.E., Eds., Cold Spring Harbor Laboratory Press, Plainview, NY, 1997, chap. 12.
226. Hasday, J.D., Fairchild, K.D., and Shanholtz, C., The role of fever in the infected host, Microbes Infect., 2, 1891, 2000.
227. Holsapple, M.P., Autoimmunity by pesticides: a critical review of the state of the science, Toxicol. Lett., 127, 101, 2002.
228. Jain, J., McCaffrey, P.G., Miner, Z., Kerppola, T.K., Lambert, J.N., Verdine, G.L., Curran, T., and Rao, A., The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun, Nature, 365, 352, 1993.
229. Kimber, I. and Dearman, R.J., Immune responses: adverse versus non-adverse effects, Toxicol. Pathol., 30, 54, 2002.
230. Nossal, G.J.V., Life, death and the immune system, Sci. Am., 269, 52, 1993.
231. Nossal, G.J.V., The double helix and immunology, Nature, 421, 414, 2003.
232. Selgrade, M.K., Germolec, D.R., Luebke, R.W., Smialowicz, R.J., Ward, M.D., and Sailstad, D.M., Immunotoxicity, in Introduction to Biochemical Toxicology, Hodgson, E. and Smart, R.C., Eds., Elsevier, New York, 2001, chap. 23.
233. Barthalmus, G.T., Terrestrial organisms, in Introduction to Environmental Toxicology, Guthrie, F.E. and Perry, J.J., Eds., Elsevier, New York, 1980.
234. Connell, D.W. and Miller, G.J., Chemistry and Ecotoxicology of Pollution, John Wiley & Sons, New York, 1984, chaps. 4 and 16.
235. Escher, B.I.K. and Hermens, J.J.M., Modes of action in ecotoxicology: their role in body burdens, species sensitivity, QSARs, and mixture effects, Environ. Sci. Technol., 36, 4201, 2002.
236. Fairbrother, A., Lewis, M.A., and Menzer, R.E., Methods in environmental toxicology, in Principles and Methods of Toxicology, 4th ed., Hayes, A.W., Ed., Taylor & Francis, Philadelphia, 2001, chap. 37.
237. Freedman, B., Environmental Ecology, Academic Press, San Diego, CA, 1994.
238. Jha, A.N., Genotoxicological studies in aquatic organisms: an overview, Mutation Res., 552, 1, 2004.
239. Kendall, R.J., Anderson, T.A., Baker, R.J., Bens, C.M., Carr, J.A., Chiodo, L.A., Cobb, G.P., III, Dickerson, R.L., Dixon, K.R., Frame, L.T., Hooper, M.J., Martin, C.F., McMurry, S.T., Patine, R., Smith, E.E., and Theodorakis, C.W., Ecotoxicology, in Casarett and Doull’s Toxicology, Klaassen, C.D., Ed., McGraw-Hill, New York, 2001, chap. 29.
240. Mackay, D. and Webster, E., A perspective on environmental models and QSARs, SAR QSAR Environ. Res., 14, 7, 2003.
241. Nandi, S., Maurer, J.J., Hofacre, C., and Summers, A.O., Gram-positive bacteria are a major reservoir of class 1 antibiotic resistance integrons in poultry litter, Proc. Natl. Acad. Sci. U.S.A., 101, 7118, 2004.
242. Pretti, C. and Cognetti-Varriale, A.M., The use of biomarkers in aquatic biomonitoring: the example of esterases, Aquatic Conserv. Mar. Freshwater Ecosyst., 11, 299, 2001.
243. Rowe-Magnus, D.A., Guerout, A.M., Ploncard, P., Dychinco, B., Davies, J., and Mazel, D., The evolutionary history of chromosomal super-integrons provides an ancestry for multiresistant integrons, Proc. Natl. Acad. Sci. U.S.A., 98, 652, 2001.
244. Snell, T.W., Brogdon, S.E., and Morgan, M.B., Gene expression profiling in ecotoxicology, Ecotoxicology, 12, 475, 2003.
245. Travis, C.C., Bishop, W.E., and Clarke, D.P., The genomic revolution: what does it mean for human and ecological risk assessment?, Ecotoxicology, 12, 489, 2003.
246. Barry, B.W., Novel mechanisms and devices to enable successful transdermal drug delivery, Eur. J. Pharm. Sci., 14, 101, 2001.
247. Bell, J.I., The double helix in clinical practice, Nature, 421, 414, 2003.
248. Benet, L.Z., Kroetz, D.L., and Sheiner, L.B., Pharmacokinetics: the dynamics of drug absorption, distribution, and elimination, in Goodman and Gilman’s: The Pharmacological Basis of Therapeutics, 9th ed., Hardman, J.G., Limbird, L.E., Molinoff, P.B., Ruddon, R.W., and Gilman, A.G., Eds., McGraw-Hill, New York, 1996.
249. Castle, A.L., Carver, M.P., and Mendrick, D.L., Toxicogenomics: a new revolution in drug safety, Drug Discovery Today, 7, 728, 2002.
250. Dorato, M.A. and Vodicnik, M.J., The toxicological assessment of pharmaceutical and biotechnology products, in Principles and Methods of Toxicology, 4th ed., Hayes, A.W., Ed., Taylor & Francis, Philadelphia, 2001.
251. Gillies, E.R. and Frechet, J.M.J., Dendrimers and dendritic polymers in drug delivery, Drug Discovery Today, 10, 35, 2005.
252. Hellmold, H., Nilsson, C.B., Schuppe-Koistinen, I., Kenne, K., and Warngard, L., Identification of end points relevant to detection of potentially adverse drug reactions, Toxicol. Lett., 127, 249, 2002.
253. Nies, A.S. and Spielberg, S.P., Principles of therapeutics, in Goodman and Gilman’s: The Pharmacological Basis of Therapeutics, 9th ed., Hardman, J.G., Limbird, L.E., Molinoff, P.B., Ruddon, R.W., and Gilman, A.G., Eds., McGraw-Hill, New York, 1996.
254. Orive, G., Gascon, A.R., Hernandez, R.M., Dominguez-Gil, A., and Pedraz, J.L., Techniques: new approaches to the delivery of biopharmaceuticals, Trends Pharmacol. Sci., 25, 382, 2004.
255. Rados, C., Inside clinical trials. Testing medical products in people, FDA Consumer, September/October 2003.
256. Redfern, W.S., Wakefield, I.D., Prior, H., Pollard, C.E., Hammond, T.G., and Valintin, J.-P., Safety pharmacology: a progressive approach, Fundam. Clin. Pharmacol., 16, 161, 2002.
257. Ross, E.M., Pharmacodynamics: the mechanisms of drug action and the relationship between drug concentration and effect, in Goodman and Gilman’s: The Pharmacological Basis of Therapeutics, 9th ed., Hardman, J.G., Limbird, L.E., Molinoff, P.B., Ruddon, R.W., and Gilman, A.G., Eds., McGraw-Hill, New York, 1996.
258. Temsamani, J. and Vidal, P., The use of cell-penetrating peptides for drug delivery, Drug Discovery Today, 9, 1012, 2004.
259. Valenta, C. and Auner, B.G., The use of polymers for dermal and transdermal delivery, Eur. J. Pharm. Biopharm., 58, 279, 2004.
260. Balikova, M., Collective poisoning with hallucinogenous herbal tea, Forensic Sci. Int., 128, 50, 2002.
261. Brown, T.M. and Grothusen, J.R., High-performance liquid chromatography of 4-nitrophenyl organophosphinates and chiral-phase separation of enantiomers, J. Chromatogr., 294, 390, 1984.
262. Bryson, P.K. and Brown, T.M., Reactivation of carboxylesterhydrolase following inhibition by 4-nitrophenyl organophosphinates, Biochem. Pharmacol., 34, 1789, 1985.
263. Drummer, O.H., Postmortem toxicology of drugs of abuse, Forensic Sci. Int., 142, 101, 2004.
264. Fisher, B.A.J., Techniques of Crime Scene Investigation, 6th ed., CRC Press, Boca Raton, FL, 2000.
265. Grothusen, J.R. and Brown, T.M., Stereoselectivity of acetylcholinesterase, arylester hydrolase and chymotrypsin toward 4-nitrophenyl alkyl(phenyl)phosphinates, Pest. Biochem. Physiol., 26, 100, 1986.
266. Hobbs, W.R., Rall, T.W., and Verdoorn, T.A., Hypnotics and sedatives: ethanol, in Goodman and Gilman’s: The Pharmacological Basis of Therapeutics, 9th ed., Hardman, J.G., Limbird, L.E., Molinoff, P.B., Ruddon, R.W., and Gilman, A.G., Eds., McGraw-Hill, New York, 1996.
267. Introna, F., Campobasso, C.P., and Goff, M.L., Entomotoxicology, Forensic Sci. Int., 120, 42, 2001.
268. O’Brien, C.P., Drug addiction and drug abuse, in Goodman and Gilman’s: The Pharmacological Basis of Therapeutics, 9th ed., Hardman, J.G., Limbird, L.E., Molinoff, P.B., Ruddon, R.W., and Gilman, A.G., Eds., McGraw-Hill, New York, 1996.
269. Olsnes, S., The history of ricin, abrin, and related toxins, Toxicon, 22, 361, 2004.
270. Poklis, A., Forensic toxicology, in Introduction to Forensic Sciences, 2nd ed., Eckert, W.G., Ed., CRC Press, Boca Raton, FL, 1997, chap. 8.
271. Poklis, A., Analytic/forensic toxicology, in Casarett and Doull’s Toxicology, Klaassen, C.D., Ed., McGraw-Hill, New York, 2001, chap. 31.
272. Reisine, T. and Pasternak, G., Opioid analgesics and antagonists, in Goodman and Gilman’s: The Pharmacological Basis of Therapeutics, 9th ed., Hardman, J.G., Limbird, L.E., Molinoff, P.B., Ruddon, R.W., and Gilman, A.G., Eds., McGraw-Hill, New York, 1996.
273. Saferstein, R., Criminalistics, 7th ed., Prentice Hall, Upper Saddle River, NJ, 2001.
274. Skopp, G., Preanalytic aspects in postmortem toxicology, Forensic Sci. Int., 142, 75, 2004.
275. Stahl, E., Ed., Thin Layer Chromatography, A Laboratory Handbook, 2nd ed., Springer-Verlag, Berlin, 1969.
276. Trestrail, J.H., III, Criminal Poisoning, Humana Press, Totowa, NJ, 2001.
277. Wang, Z., Wen, J., Zhang, J., Ye, M., and Guo, D., Simultaneous determination of four bufadienolides in human liver by high-performance liquid chromatography, Biomed. Chromatogr., 18, 318, 2004.
278. Borgmann, U., Metal speciation and toxicity of free metal ions to aquatic biota, in Aquatic Toxicology, Nriagu, J.O., Ed., John Wiley & Sons, New York, 1983, chap. 2.
279. Bronmark, C. and Hansson, L.-A., Environmental issues in lakes and ponds: current state and perspectives, Environ. Conserv., 29, 290, 2002.
280. Brown, M.P., Werner, M.B., Sloan, R.J., and Simpson, K.W., Polychlorinated biphenyls in the Hudson River, Environ. Sci. Technol., 19, 656, 1985.
281. Brown, P. and Clapp, R., Looking back on Love Canal, Public Health Rep., 117, 95, 2002.
282. Cooter, W.S., Clean water act assessment processes in relation to changing U.S. Environmental Protection Agency management strategies, Environ. Sci. Technol., 38, 5265, 2004.
283. Costa, D.L., Air pollution, in Casarett and Doull’s Toxicology, Klaassen, C.D., Ed., McGraw-Hill, New York, 2001, chap. 28.
284. DePinto, J.V., Young, T.C., and McIlroy, L.M., Great Lakes water quality improvement, Environ. Sci. Technol., 20, 752, 1986.
285. Echobichon, D.J., Toxic effects of pesticides, in Casarett and Doull’s Toxicology, Klaassen, C.D., Ed., McGraw-Hill, New York, 2001, chap. 22.
286. Englande, A.J.J. and Eckenfelder, W.W.J., Toxic waste management in the chemical and petrochemical industries, Water Sci. Technol., 25, 286, 1991.
287. Freedman, B., Environmental Ecology, Academic Press, San Diego, 1989, chap. 6.
288. Heckman, C.W., Reactions of aquatic ecosystems to pesticides, in Aquatic Toxicology, Nriagu, J.O., Ed., John Wiley & Sons, New York, 1983, chap. 12.
289. Hoffman, A.J., An uneasy rebirth at Love Canal, Environment, 37, 4, 1995.
290. Holloway, M., Soiled shores, Scientific American, October 1991, p. 102.
291. Houghton, R.A. and Woodwell, G.M., Global climatic change, Sci. Am., 260, 36, 1989.
292. Huggett, R.J., Unger, M.A., Seligman, P.F., and Valkirs, A.O., The marine biocide tributyltin, Environ. Sci. Technol., 26, 232, 1992.
293. Jeffries, D.S., Brydges, T.G., Dillon, P.J., and Keller, W., Monitoring the results of Canada/U.S.A. acid rain control programs: some lake responses, Environ. Monitor. Assess., 88, 3, 2003.
294. Jones, P.D. and Wigley, T.M.L., Global warming trends, Sci. Am., 263, 84, 1990.
295. Laxen, D.P.H., The chemistry of metal pollutants in water, in Pollution: Causes, Effects, and Control, Harrison, R.M., Ed., Royal Society of Chemistry, London, 1982, chap. 6.
296. Lin, G.-H., Sauer, N.E., and Cutright, T.J., Environmental regulations: a brief overview of their applications to bioremediation, Int. Biodeterior. Biodegrad., 38, 1, 1996.
297. Lyons, R.A., Temple, J.M.F., Evans, D., Fone, D.L., and Palmer, S.R., Acute health effects of the Sea Empress spill, J. Epidemiol. Commun. Health, 53, 306, 1999.
298. Makarewicz, J.C. and Bertram, P., Evidence for the restoration of the Lake Erie ecosystem, Bioscience, 41, 216, 1991.
299. Maynard, R., Key airborne pollutants: the impact on health, Sci. Total Environ., 334/335, 9, 2004.
300. Menzer, R.E., Water and soil pollutants, in Casarett and Doull’s Toxicology, Amdur, M.O., Doull, J., and Klaassen, C.D., Eds., Pergamon Press, New York, 1991, chap. 26.
301. 2 and global warming in a multi-factor world, New Phytol., 162, 281, 2004.
302. Schindler, D.W., Effects of acid rain on freshwater ecosystems, Science, 239, 149, 1988.
303. Short, J.W., Lindeberg, M.R., Hrris, P.M., Maselko, J.M., Pella, J.J., and Rice, S.D., Estimate of oil persisting on the beaches of Prince William Sound 12 years after the Exxon Valdez oil spill, Environ. Sci. Technol., 38, 19, 2004.
304. Stern, D.I., Global sulfur emissions from 1850 to 2000, Chemosphere, 58, 163, 2005.
305. United Nations Environment Programme, Environmental Effects Assessment Panel, Environmental effects of ozone depletion and its interactions with climate change: progress report, 2004, Photochem. Photobiol. Sci., 22, 177, 2005.
306. U.S. Environmental Protection Agency, National Priorities List under the Original Hazard Ranking System 1981–1991, Fact Book 9320.7-08, EPA 540-R-93-079, EPA Office of Solid Waste and Emergency Response, 1993.
307. U.S. Environmental Protection Agency, National priorities list for uncontrolled hazardous waste sites, Fed. Reg., 59, 27989, 1994.
308. U.S. Environmental Protection Agency, Superfund website, http://www.epa.gov/superfund/index.htm.
309. White, R.M., The great climate debate, Sci. Am., 263, 36, 1990.
310. Whittaker, A., BeruBe, K., Jones, T., Maynard, R., and Richards, R., Killer smog of London, 50 years on: particle properties and oxidative capacity, Sci. Total Environ., 334/335, 435, 2004.